Integrating ESG in Drug Development Strategy for Pharmaceutical Companies
Integrating ESG factors into drug development strategy is critical for pharmaceutical companies seeking to meet the evolving expectations of stakeholders, foster innovation, reduce risk, and create long-term value. By understanding the key ESG factors relevant to drug development and following a comprehensive framework for ESG integration, pharmaceutical companies can optimize their drug development processes, leading to more sustainable and equitable outcomes. In doing so, they can enhance their reputations, generate long-term value for their stakeholders, and contribute to a healthier and more sustainable world.
